Cargando…

Brain-type and liver-type fatty acid-binding proteins: new tumor markers for renal cancer?

BACKGROUND: Renal cell carcinoma (RCC) is the most common renal neoplasm. Cancer tissue is often characterized by altered energy regulation. Fatty acid-binding proteins (FABP) are involved in the intracellular transport of fatty acids (FA). We examined the level of brain-type (B) and liver-type (L)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tölle, Angelika, Jung, Monika, Lein, Michael, Johannsen, Manfred, Miller, Kurt, Moch, Holger, Jung, Klaus, Kristiansen, Glen
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2732640/ https://www.ncbi.nlm.nih.gov/pubmed/19622156 http://dx.doi.org/10.1186/1471-2407-9-248

Ejemplares similares

ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression
por: Fritzsche, Florian R, et al.
Publicado: (2008)

Down-regulation of the pro-apoptotic XIAP associated factor-1 (XAF1) during progression of clear-cell renal cancer
por: Kempkensteffen, Carsten, et al.
Publicado: (2009)

Fatty acid binding proteins (FABPs) in prostate, bladder and kidney cancer cell lines and the use of IL-FABP as survival predictor in patients with renal cell carcinoma
por: Tölle, Angelika, et al.
Publicado: (2011)

GOLPH2 expression in renal cell cancer
por: Fritzsche, Florian Rudolf, et al.
Publicado: (2008)

The FUSE binding proteins FBP1 and FBP3 are potential c-myc regulators in renal, but not in prostate and bladder cancer
por: Weber, Achim, et al.
Publicado: (2008)

In search of suitable reference genes for gene expression studies of human renal cell carcinoma by real-time PCR
por: Jung, Monika, et al.
Publicado: (2007)

MicroRNA profiling of clear cell renal cell cancer identifies a robust signature to define renal malignancy
por: Jung, Monika, et al.
Publicado: (2009)

GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnostics
por: Kristiansen, G, et al.
Publicado: (2008)

Sensitivity of HOXB13 as a Diagnostic Immunohistochemical Marker of Prostatic Origin in Prostate Cancer Metastases: Comparison to PSA, Prostein, Androgen Receptor, ERG, NKX3.1, PSAP, and PSMA
por: Kristiansen, Ilka, et al.
Publicado: (2017)

Urinary Liver-Type Fatty Acid–Binding Protein and Progression of Diabetic Nephropathy in Type 1 Diabetes
por: Panduru, Nicolae M., et al.
Publicado: (2013)

Renal cell neoplasias: reversion-inducing cysteine-rich protein with Kazal motifs discriminates tumor subtypes, while extracellular matrix metalloproteinase inducer indicates prognosis
por: Rabien, Anja, et al.
Publicado: (2013)

Renal expression and urinary excretion of liver‐type fatty acid‐binding protein in cats with renal disease
por: Katayama, Masaaki, et al.
Publicado: (2020)

Metabolic profiling reveals key metabolic features of renal cell carcinoma
por: Catchpole, Gareth, et al.
Publicado: (2011)

Retroperitoneal teratoma with somatic malignant transformation: A papillary renal cell carcinoma in a testicular germ cell tumour metastasis following platinum-based chemotherapy
por: Zeh, Nina, et al.
Publicado: (2013)

Adipophilin as prognostic biomarker in clear cell renal cell carcinoma
por: Tolkach, Yuri, et al.
Publicado: (2017)

Clinical evaluation of urinary liver-type fatty acid-binding protein for the diagnosis of renal diseases in dogs
por: TAKASHIMA, Satoshi, et al.
Publicado: (2021)

Urinary liver‐type fatty acid‐binding protein as a prognostic marker in patients with acute heart failure
por: Sunayama, Tsutomu, et al.
Publicado: (2021)

Loss of cadherin related family member 5 (CDHR5) expression in clear cell renal cell carcinoma is a prognostic marker of disease progression
por: Bläsius, Felix Marius, et al.
Publicado: (2017)

Tissue-Based MicroRNAs as Predictors of Biochemical Recurrence after Radical Prostatectomy: What Can We Learn from Past Studies?
por: Zhao, Zhongwei, et al.
Publicado: (2017)

Serum Levels of Adipocyte Fatty Acid-Binding Protein Are Associated with Rapid Renal Function Decline in Patients with Type 2 Diabetes Mellitus and Preserved Renal Function
por: Seo, Da Hea, et al.
Publicado: (2020)

Urinary Liver-Type Fatty Acid-Binding Protein Predicts Residual Renal Function Decline in Patients on Peritoneal Dialysis
por: Torigoe, Kenta, et al.
Publicado: (2020)

Class I histone deacetylases 1, 2 and 3 are highly expressed in renal cell cancer
por: Fritzsche, Florian R, et al.
Publicado: (2008)

Human heart-type fatty acid-binding protein as an early diagnostic marker of doxorubicin cardiac toxicity
por: ElGhandour, Ashraf H., et al.
Publicado: (2009)

Urinary liver-type fatty acid binding protein and chronic kidney disease
por: Kamijo-Ikemori, A., et al.
Publicado: (2015)

GOLPH2 expression may serve as diagnostic marker in seminomas
por: Fritzsche, Florian R, et al.
Publicado: (2010)

Urinary Liver-Type Fatty Acid-Binding Protein Predicts Progression to Nephropathy in Type 1 Diabetic Patients
por: Nielsen, Stine Elkjaer, et al.
Publicado: (2010)

Biomarker discovery for renal cancer stem cells
por: Corrò, Claudia, et al.
Publicado: (2018)

Predictive Effects of Urinary Liver-Type Fatty Acid–Binding Protein for Deteriorating Renal Function and Incidence of Cardiovascular Disease in Type 2 Diabetic Patients Without Advanced Nephropathy
por: Araki, Shin-ichi, et al.
Publicado: (2013)

Apelin and apelin receptor expression in renal cell carcinoma
por: Tolkach, Yuri, et al.
Publicado: (2019)

The Role of Urinary Liver-Type Fatty Acid-Binding Protein in Critically Ill Patients
por: Cho, Eunjung, et al.
Publicado: (2013)

Clinical Significance of Urinary Liver-Type Fatty Acid–Binding Protein in Diabetic Nephropathy of Type 2 Diabetic Patients
por: Kamijo-Ikemori, Atsuko, et al.
Publicado: (2011)

Inhibition of TNFalpha in vivo prevents hyperoxia-mediated activation of caspase 3 in type II cells
por: Guthmann, Florian, et al.
Publicado: (2005)

Renal impairment markers in type 2 diabetes patients with different types of hyperuricemia
por: Gao, Zhongai, et al.
Publicado: (2018)

Urinary l-type fatty acid-binding protein is a predictor of early renal function after partial nephrectomy
por: Yanishi, Masaaki, et al.
Publicado: (2016)

Non-Alcoholic Fatty Liver Disease in Obese Youth With Insulin Resistance and Type 2 Diabetes
por: Scapaticci, Serena, et al.
Publicado: (2021)

Piwi-interacting RNAs as novel prognostic markers in clear cell renal cell carcinomas
por: Busch, Jonas, et al.
Publicado: (2015)

Current Metabolic Status Affects Urinary Liver-Type Fatty-Acid Binding Protein in Normoalbuminuric Patients With Type 2 Diabetes
por: Ito, Hiroyuki, et al.
Publicado: (2017)

Clinical significance of urinary liver-type fatty acid binding protein at various stages of nephropathy
por: Viswanathan, V., et al.
Publicado: (2015)

KWASHIORKOR TYPE OF FATTY LIVER IN PRIMATES
por: Wilgram, George F., et al.
Publicado: (1958)

Serum Adipocyte Fatty-Acid Binding Protein as an Independent Marker of Peripheral Artery Disease in Patients with Type-2 Diabetes Mellitus
por: Hsu, Bang-Gee, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_d0tjm36jbhgcjjjoauqbvth5a8